Congress Passes Sweeping Health Care Bill

U.S. News & World Report, December 7, 2016. We opposed the 21st Century Cures bill. It passed anyway. Drug and device companies are popping the champagne. Republicans bought off the White House by promising research $$ for pet projects. How will the law affect you?

Read More »

Why the 21st Century Cures Act Could Be Disastrous for Medicine

Spectrum News, December 1, 2016. Why would anyone vote against “cures,” especially “21st century cures?” Here’s why many health policy and consumer advocacy groups — including the National Center for Health Research — strongly oppose the bill and are asking senators not to pass the bill next week.

Read More »

Cancer Drugs May Remain Approved Despite Lack of Benefit

Reuters, December 1, 2016. Researchers evaluated studies done on 18 cancer drugs approved between 2008 and 2012 by the FDA. None of the drugs had been found to prolong life, and only one had enough evidence to say it improved quality of life. Yet, all but one retained its approval status.

Read More »

To Fund Projects Like the Cancer Moonshot, Congress Had to Strip Away Some of the FDA’s Most Important Regulatory Powers

Quartz, December 1, 2016. The 21st Century Cures Act passed in the House, but comes with a lot of regulatory compromise and threats to patient safety. Most notably, Senator Warren and Senator Sanders oppose the bill along with NCHR President Diana Zuckerman due to patient safety concerns and breaks for Big Pharma. “It really is a David and Goliath issue of where the money is,” said Dr. Zuckerman.

Read More »